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Transient activation of the hypothalamic–pituitary–gonadal axis in early infancy plays an
important role in male genital development and sexual differentiation of the brain, but
factors contributing to individual variation in testosterone levels during this period are
poorly understood. We measured salivary testosterone levels in 222 infants (119 males,
103 females, 108 singletons, 114 twins) between 2.70 and 4.80 months of age. We tested
16 major demographic and medical history variables for effects on inter-individual variation
in salivary testosterone. Using the subset of twins, we estimated genetic and environ-
mental contributions to salivary testosterone levels. Finally, we tested single nucleotide
polymorphisms (SNPs) within±5 kb of genes involved in testosterone synthesis, transport,
signaling, and metabolism for associations with salivary testosterone using univariate tests
and random forest (RF) analysis. We report an association between 5 min APGAR scores
and salivary testosterone levels in males.Twin modeling indicated that individual variability
in testosterone levels was primarily explained by environmental factors. Regarding genetic
variation, univariate tests did not reveal any variants significantly associated with salivary
testosterone after adjusting for false discovery rate. The top hit in males was rs10923844,
an SNP of unknown function located downstream of HSD3B1 and HSD3B2. The top hits
in females were two SNPs located upstream of ESR1 (rs3407085 and rs2295190). RF
analysis, which reflects joint and conditional effects of multiple variants, indicated that
genes involved in regulation of reproductive function, particularly LHCGR, are related to
salivary testosterone levels in male infants, as are genes involved in cholesterol production,
transport, and removal, while genes involved in estrogen signaling are related to salivary
testosterone levels in female infants.
Keywords: testosterone, twins, infancy, APGAR, LHCGR, hypothalamic–pituitary–gonadal axis, minipuberty,
neonate
INTRODUCTION
Transient activation of the hypothalamic–pituitary–gonadal
(HPG) axis in the early post-natal period results in elevated levels
of gonadotropins and testosterone in human males, a phenome-
non known as the “minipuberty” or “neonatal surge” (1–5). The
consequences of this activation are not fully understood, but it
likely plays an important role in genital development (6–9) and
has been linked to future fertility (10). There is also an increasing
body of evidence that this is a critical period for the development
of sexually dimorphic behavior and psychopathology (11–16).
Understanding the causes of individual variation in testosterone
levels during the minipuberty is thus of considerable theoretical
and clinical interest.
Levels of pubertal and post-pubertal testosterone in males are
determined, in part, genetically, with heritability estimates around
40–70% (17–23) for both salivary and plasma measures. Stud-
ies in females are less consistent with some reporting minimal
heritable variation (23) and others reporting heritabilities sim-
ilar to those seen in males (17, 20, 22). Recently, genome-wide
association studies (GWAS) have been used to identify single
nucleotide polymorphisms (SNPs) associated with serum lev-
els of testosterone in adults. Ohlsson et al. (24) identified two
loci that met genome-wide significance for serum testosterone
levels in men of European ancestry, one in the gene for sex
hormone-binding globulin (SHBG, lead SNPs rs12150660 and
rs6258) and one near family with sequence similarity 9, member
B (FAM9B) on Xp22 (lead SNP rs5934505). Jin et al. (25) con-
firmed both loci in an independent study, although the lead SNP
in the SHBG locus differed (rs727428). They also reported a new
hit at rs10822184, which is located in receptor accessory protein
3 (REEP3). Chen et al. (26) reported a significant association
between rs2075230 in the SHBG locus and serum testosterone
in a sample of Chinese men. A GWAS of 1600 post-menopausal
women failed to find any genome-wide significant associations
with testosterone (27).
There is evidence to suggest that distinct genetic mechanisms
influence testosterone levels across developmental time (17), so it is
theoretically possible that the relative importance of genetic factors
and the specific variants involved may be different in the minipu-
berty. Indeed, a study of salivary testosterone in twins between
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4 and 8 months of age reported that variation was completely
explained by common and unique environmental factors (28).
This result is extremely intriguing, but the age range studied
is slightly beyond the minipuberty as classically defined. Most
studies suggest that the post-natal surge in testosterone peaks
in males between 1 and 3 months of age and declines signifi-
cantly by 6 months of age (4, 5, 29, 30). The gonads are the main
source of testosterone in males during the minipuberty, but after
6 months the adrenal becomes the primary source of testosterone
(31) as a consequence of the regression and degeneration of neona-
tal Leydig cells (32). Complementary studies at earlier ages are
therefore needed as are studies looking at the impact of specific
environmental factors.
The current study takes advantage of an ongoing GWAS of
infant brain development being carried out at the University of
North Carolina (UNC) at Chapel Hill. The study includes both
twins and singletons. A subset of participating children donated
saliva samples for the assessment of salivary testosterone around
3 months of age [see Ref. (33)]. We used this sample to estimate
genetic and environmental contributions to salivary testosterone
levels during the minipuberty. We also examined the impact of
16 major demographic and medical history variables on inter-
individual variation in salivary testosterone. In addition, we tested
SNPs within ±5 kb of genes involved in testosterone synthesis,
transport, signaling, and metabolism for their relationship with
salivary testosterone. We also tested SNPs in REEP3 and the Xp22
loci identified in GWAS studies of serum testosterone in adult
males to see if these were predictive in infants. Finally, to address
the issue of potentially small effect sizes for individual SNPs, as
well as non-additive effects, we used random forest (RF) meth-
ods to identify combinations of SNPs contributing to variation in
salivary testosterone in infancy.
MATERIALS AND METHODS
SUBJECTS
Two-hundred twenty-two infants (119 males, 103 females)
between 2.70 and 4.80 months of age (mean age 3.34 months post-
date of birth± 0.36) with high quality genetic information and
saliva samples suitable for hormone assay are included in this
analysis. The sample includes 108 singletons and 114 twins (27
same-sex DZ pairs, 27 same-sex MZ pairs, 2 opposite-sex DZ pairs,
and 2 unpaired twins). All children were participating in prospec-
tive longitudinal studies of early brain development for which the
senior author is a co-investigator. Mothers were recruited during
the second trimester of pregnancy from the outpatient obstet-
rics and gynecology clinics at UNC hospitals. Exclusion criteria at
enrollment were the presence of abnormalities on fetal ultrasound
or major medical illness in the mother. Demographic variables
(maternal age, paternal age, maternal education, paternal educa-
tion, maternal ethnicity, paternal ethnicity, maternal psychiatric
history, paternal psychiatric history, and total household income)
were collected via maternal report at the time of enrollment (see
Supplementary Material). For the purpose of the current study,
maternal psychiatric history and paternal psychiatric history were
treated as binary variables. Individuals were counted as positive for
psychiatric history if they had received any psychiatric diagnosis.
Medical history variables (birth weight, gestational age at birth,
5 min APGAR scores, stay in neonatal intensive care unit over
24 h, gestation number, and delivery method) were collected from
maternity and pediatric medical records shortly after birth (see
Supplementary Material). Maternal smoking during pregnancy
was collected via maternal report at two timepoints during preg-
nancy and shortly after birth. Demographic and medical history
data are summarized in Table 1. Experiments were undertaken
with the understanding and written consent of each subject’s
mother or father, with the approval of the Institutional Review
Board of the UNC School of Medicine.
Table 1 | Demographic and medical history information.
Male (N =119) Female (N =103)
CONTINUOUS VARIABLES Mean (SD)
Age since DOBa (months) 3.32 (0.36) 3.36 (0.37)
Gestational age at birth (weeks) 37.3 (3.0) 37.7 (2.3)
Birth weight (g) 2886 (816) 2910 (563)
5-Min APGAR Score 8.7 (0.7) 8.6 (0.7)
Maternal age (years) 29.7 (6.1) 30.3 (5.4)
Paternal age (years) 31.5 (5.9) 32.5 (6.1)
Maternal education (years) 15.7 (3.3) 15.7 (3.0)
Paternal education (years) 15.7 (3.1) 15.0 (3.0)
CATEGORICAL VARIABLES NO. (%)
Gestation number Twin 65 (55%) Twin 49 (48%)
Singleton 54 (45%) Singleton 54 (52%)
NICU stay >24 h No 98 (82%) No 86 (83%)
Yes 21 (18%) Yes 17 (17%)
Caesarian section No 60 (50%) No 56 (54%)
Yes 59 (50%) Yes 47 (46%)
Maternal ethnicity White 89 (75%) White 82 (80%)
Black 24 (20%) Black 20 (19%)
Asian 4 (3%) Asian 1 (1%)
Other 2 (1%)
Paternal ethnicity White 86 (72%) White 81 (79%)
Black 26 (22%) Black 19 (18%)
Asian 7 (6%) Asian 3 (3%)
Maternal psychiatric history No 93 (78%) No 81 (79%)
Yes 26 (22%) Yes 22 (21%)
Paternal psychiatric history No 103 (87%) No 94 (91%)
Yes 16 (13%) Yes 9 (9%)
Incomeb High (29%) High (33%)
Middle (39%) Middle (37%)
Low (30%) Low (28%)
Missing (2%) Missing (2%)
Maternal smoking No 107 (90%) No 93 (90%)
Yes 12 (10%) Yes 10 (10%)
aDOB=date of birth,
b low income: at or below 200% of federal poverty level (FPL), middle income:
between 200 and 400% of FPL, high income: above 400% of FPL.
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SALIVARY ASSAYS
Saliva samples were collected during visits to participants’ homes.
Visits were scheduled for 9:00 a.m. Mean± SD for collection start
time was 9:14 a.m.± 16 min. Parents were advised not to feed
their children for at least 15 min prior to collection. One milliliter
of passive drool was collected from each participant using a suc-
tion catheter (Centurion Healthcare Products, Howell, MO, USA).
Mean± SD for duration of collection was 4± 2 min. All samples
were frozen within 5 h and stored in a−80 °C freezer. Mean± SD
for time until storage was 60± 31 min.
Salivary testosterone levels were measured by enzyme
immunoassay using a commercially available kit (Salimetrics, State
College, PA, USA). The intra-assay precision for samples with low
testosterone levels (mean 18.12 pg/ml) is 6.7%; for high testos-
terone levels (mean 188.83 pg/ml) it is 2.5%. Inter-assay precision
for samples with low testosterone levels (mean 19.6 pg/ml) is
14.05%; for high testosterone levels (mean 199.08 pg/ml) it is
5.6%. Percent recovery for this assay varies from 92 to 111.4%. The
minimal concentration of testosterone that can be distinguished
from 0 is <1.0 pg/ml. Only one sample had a concentration
below the detection limit. This sample was coded as 0 pg/ml in
subsequent analyses. We also evaluated all samples for blood con-
tamination using the Salimetrics Salivary Blood Contamination
Enzyme Immunoassay kit, which quantitatively measures trans-
ferrin, a large protein, which is present in abundance in blood, but
that is normally present in only trace amounts in saliva. Intra-assay
precision for samples with high (3.88 mg/dl) transferrin levels is
10.2%, for samples with low (0.42 mg/dl) transferrin levels it is
4.9%. Inter-assay precision is 7.1% for low (1.02 mg/dl) and 7.2%
for high (4.93 mg/dl) transferrin levels. Percent recovery varies
from 91.9 to 101.5%. The minimal concentration of transferrin
that can be distinguished from zero is 0.08 mg/dl.
GENOTYPING
DNA was extracted from buccal cells using standard methods as
described in the Puregene® DNA Purification Kit (Gentra Sys-
tems) or using phenol/chloroform. After extraction, samples were
stored in a −80 °C freezer until analysis. Genotyping was car-
ried out at the Bionomics Research and Technology Center at
Rutgers (Piscataway, NJ, USA) using Affymetrix Axiom Genome-
Wide LAT and Exome arrays. Samples were randomized across
96-well plates. Each plate contained a common control sample.
Genotype calling was performed with the Affymetrix Genotyp-
ing Console. Rigorous quality control procedures were carried
out prior to analysis. In brief, we excluded samples with low
DishQC (<0.82 for LAT array and <0.79 for Exome array), low
call rates (<95%), outliers for homozygosity, sex, or zygosity from
genotypes inconsistent with reported phenotypes, ancestry out-
liers, excessive relatedness, and unexpected relatedness. We also
removed individual SNPs that deviated from Hardy–Weinberg
equilibrium (PHWE < 1× 10−8), had low call rate (<95%), high
deviation of allele frequency from 1000G EUR/AFR founders, and
that did not match 1000G EUR/AFR founders. Population strat-
ification was assessed using principal component analysis (PCA)
(34, 35). Population stratification is the presence of systematic
differences in allele frequencies between subpopulations with dif-
ferent genetic ancestry and can lead to spurious results in genetic
FIGURE 1 | Scree plot demonstrating that the majority of genetic
variation is explained by the first three PCs.
association studies. We first pruned the genotyped SNPs using
the pruning tool in PLINK (36). We then created a subset of our
total GWAS sample without related subjects by randomly selecting
one individual from twin and sibling pairs (all non-twins/non-
sibs were also included). Smartpca in EIGENSOFT was applied
to compute the principal components (PCs or eigenvectors). The
first three PCs explain 6.8% of the variability in genetic variables.
See Figures 1 and 2 for a scree plot and 3D scatter plots of the first
three PCs color-coded by maternal and paternal reported ethnicity.
Strong clustering of subjects with similar reported ethnicity con-
firms that the first three PCs index genetic ancestry. Imputation
was then performed with MaCH-Admix using 1000G reference
panel (phase1_release_v3.20101123) followed by post-imputation
quality control based on imputation quality score.
For the current analysis,we extracted all genotyped SNPs within
±5 kb of genes involved in testosterone synthesis, transport, sig-
naling, and metabolism (see Table 2). We also included genotyped
SNPs in/near REEP3 and the Xp22 loci flagged in GWAS studies
of serum testosterone in adult males. Three of the top GWAS hits
in SHBG were not genotyped by either array, but were imputed
with good quality (rs727428, rs12150660, and rs2075230). The
imputed SNPs were used in the current analysis. rs6258 was
directly genotyped, but was excluded due to low minor-allele fre-
quency (MAF). Top hits in REEP3 and the Xp22 loci were also
imputed (rs10822184 and rs5934505). Additional imputed SNPs
near the Xp22 loci were also included due to the low number of
genotyped SNPs in this region. SNPs with MAF <0.05 were not
included in our analyses. In total, 512 SNPs were examined in
males and 473 SNPs were examined in females.
ENVIRONMENTAL ASSOCIATION ANALYSIS
In order to determine the potential impact of major demographic
and medical history variables on inter-individual variation in
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FIGURE 2 | 3D scatter plots of the first three PCs color-coded by maternal and paternal reported ethnicity.
salivary testosterone, we used a moment-based method to select
fixed effects in linear mixed effects models (37). Twins are treated
as repeated measures. For fixed effects selection, we applied an
adaptive Lasso penalty using the feasible generalized least squares
estimator as an initial. In the model, we always include log(10)
transferrin and age since DOB as predictors. We focused on
selecting a list of predictors including maternal age, paternal age,
maternal education, paternal education, maternal ethnicity, pater-
nal ethnicity, maternal psychiatric history, paternal psychiatric
history, total household income, maternal smoking during preg-
nancy, birth weight, gestational age at birth, 5 min APGAR scores,
stay in neonatal intensive care unit over 24 h, gestation number,
and delivery method. We used the BIC statistic to select the tuning
parameter of the adaptive Lasso as in Section 4 of Ahn et al. (37).
Before applying our variable selection method, we standardized all
covariates and centered the response variable (testosterone). We
also applied bootstrap methods 1000 times to assess the stability
of our results.
After model selection, we ran a mixed effect model using the
selected variables for significance testing and to estimate r2 val-
ues. Mixed effect models were also run including all variables for
comparison. Males and females were analyzed separately for this
and all subsequent analyses. We separated the sexes because the
source of testosterone is primarily gonadal in males and adrenal
in females during the minipuberty (31). Studies in adults also
suggest that different genetic factors influence testosterone con-
centrations in men and women (17). Variables were considered
significant if they were selected in the Lasso model and survived
Bonferroni correction in the mixed effect model including all
variables.
INTRACLASS CORRELATION COEFFICIENT AND HERITABILITY
ESTIMATION
The intraclass correlation coefficient (ICCs) and their confidence
intervals were estimated separately for MZM (monozygotic male),
DZM (dizygotic male), MZF (monozygotic female), and DZF
(dizygotic female) using R package called ICC. The heritabil-
ity was estimated using linear mixed effect model (ACE model)
while restricting variance of genetic, shared environment, and ran-
dom error to be >0. One-tailed t -tests were used to test whether
the estimates were significantly >0 (p-values <0.05 were consid-
ered significant). For males, log(10)transferrin, age since DOB,
and 5 min APGAR score were included as covariates. For females,
log(10)transferrin and age since DOB were included as covariates.
UNIVARIATE GENETIC ASSOCIATION ANALYSIS
Males and females were analyzed separately. For males,
log(10)transferrin, age since DOB, and 5 min APGAR score were
included as covariates. For females, log(10)transferrin and age
since DOB were included as covariates. In addition, the first
three principle components derived from all genotyped SNPs were
included as covariates to control for possible population strati-
fication. Association analysis was performed using mixed effect
models with likelihood ratio tests. p-values were adjusted by false
discovery rate (FDR); p-values <0.05 after FDR correction were
considered significant.
Univariate genetic association analysis provides a straightfor-
ward approach to identifying genetic variants associated with
phenotypes of interest, in this case salivary testosterone levels.
However, given the large number of tests performed, this approach
is underpowered for identifying SNPs with small effect sizes. In
addition, it does not account for genetic interactions, i.e., causal
effects that are only observed when specific combinations of muta-
tions and/or non-mutations are jointly present. In order to address
these limitations, we also carried out RF analysis to identify combi-
nations of SNPs contributing to variation in salivary testosterone
in infancy.
To gain a better understanding of the power of our univari-
ate genetic association analysis, we generated power plots using
different SNP MAFs and effect sizes (beta).
Frontiers in Endocrinology | Pediatric Endocrinology October 2014 | Volume 5 | Article 187 | 4
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Table 2 | Genes probed in the current analysis.
Gene symbol Gene name General category
CYP11A Cytochrome P450, family 11, subfamily A, polypeptide 1 Synthesis and metabolism
CYP11B1 Cytochrome P450, family 11, subfamily B, polypeptide 1 Synthesis and metabolism
CYP17A1 Cytochrome P450, family 17, subfamily A, polypeptide 1 Synthesis and metabolism
CYP19A1 Cytochrome P450, family 19, subfamily A, polypeptide 1 (Aromatase) Synthesis and metabolism
CYP1B1 Cytochrome P450, family 1, subfamily B, polypeptide 1 Synthesis and metabolism
CYP21A2 Cytochrome P450, family 21, subfamily A, polypeptide 2 Synthesis and metabolism
CYP3A4 Cytochrome P450, family 3, subfamily A, polypeptide 4 Synthesis and metabolism
CYP3A43 Cytochrome P450, family 3, subfamily A, polypeptide 43 Synthesis and metabolism
CYP3A5 Cytochrome P450, family 3, subfamily A, polypeptide 5 Synthesis and metabolism
CYP3A7 Cytochrome P450, family 3, subfamily A, polypeptide 7 Synthesis and metabolism
CYP7A1 Cytochrome P450, family 7, subfamily A, polypeptide 1 Synthesis and metabolism
DHCR7 7-dehydrocholesterol reductase Synthesis and metabolism
HSD17B1 Hydroxysteroid (17-beta) dehydrogenase 1 Synthesis and metabolism
HSD17B2 Hydroxysteroid (17-beta) dehydrogenase 2 Synthesis and metabolism
HSD17B3 Hydroxysteroid (17-beta) dehydrogenase 3 Synthesis and metabolism
HSD17B6 Hydroxysteroid (17-beta) dehydrogenase 6 Synthesis and metabolism
HSD17B7 Hydroxysteroid (17-beta) dehydrogenase 7 Synthesis and metabolism
HSD17B8 Hydroxysteroid (17-beta) dehydrogenase 8 Synthesis and metabolism
HSD3B1 Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid
delta-isomerase 1
Synthesis and metabolism
HSD3B2 Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid
delta-isomerase 2
Synthesis and metabolism
POR P450 (cytochrome) oxidoreductase Synthesis and metabolism
SRD5A1 Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta
4-dehydrogenase alpha 1)
Synthesis and metabolism
SRD5A2 Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta
4-dehydrogenase alpha 2)
Synthesis and metabolism
SRD5A3 Steroid 5 alpha-reductase 3 Synthesis and metabolism
STAR Steroidogenic acute regulatory protein Synthesis and metabolism
STS Steroid sulfatase (microsomal), isozyme S Synthesis and metabolism
SULT2A1 Sulfotransferase family, cytosolic, 2a, dehydroepiandrosterone
(DHEA)-preferring, member 1
Synthesis and metabolism
SHBG Sex hormone-binding globulin Transport
TSPO Translocator protein (18 kDa) Transport
ALB Albumin Transport
AR Androgen receptor Receptors
ESR1 Estrogen receptor alpha Receptors
ESR2 Estrogen receptor beta Receptors
CGA Glycoprotein hormones, alpha polypeptide Regulators of reproductive function
GNRH1 Gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) Regulators of reproductive function
LHB Luteinizing hormone beta polypeptide Regulators of reproductive function
GNRHR Gonadotropin-releasing hormone receptor Regulators of reproductive function
LHCGR Luteinizing hormone/choriogonadotropin receptor Regulators of reproductive function
REEP3 Receptor accessory protein 3 GWAS hit for serum testosterone
Xp22 near rs5934505 Closest gene is family with sequence similarity 9, member B GWAS hit for serum testosterone
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We used the same number of subjects (and proportion of MZs,
DZs, and singletons) as our real data and similar scale of effect
size, mean, variance, and additive genetic and shared environment
effects estimated from the real data. Ten thousand simulations
were done for each scenario and the significance level was set to
0.05/500, which is similar to our data after Bonferroni correction.
RANDOM FORESTS
Random forest analysis was implemented using R software.
The result of RF analysis reflects joint and conditional effects
of multiple variables. As variables with strong effects may
mask weaker, yet important effects, we removed the effects
of log(10)transferrin, age since DOB, 5 min APGAR score,
and the first three principle components (for males) and
log(10)transferrin, age since DOB, and the first three principle
components (for females). Specifically, we (1) used the residual
from the regression Testosterone ~log(10)transferrin+ age since
DOB+ 5 min APGAR score (males only)+PC1+PC2+PC3 as
the new response, and (2) used the residual from the regression
SNPs ~log(10)transferrin+ age since DOB+ 5 min APGAR score
(males only)+PC1+PC2+PC3 as the new predictor variables
for the RF analysis. The number of randomly preselected variables
(mtry) was set to the number of SNPs divided by 3 (p/3) as recom-
mended by Liaw and Wiener (38). We also examined the error rate
for mtry= 2p/3, 0.5p/3, and p. Error rate was highly similar across
different mtry, but p/3 produced the lowest error rate. The number
of trees (ntree) was set to 2000. RF analysis was run 50 times, each
run using different seeds for random number generation (RNG).
In each run, we recorded the 30 SNPs with the highest variable
importance. After all 50 runs were completed, we identified those
SNPs, which appeared in the “top 30 list” in every 1 of 50 runs.
Because RF analysis is not set-up to treat twins as a repeated mea-
sure, we randomly picked one twin from each twin pair to ensure
that no related subjects were included in the RF analysis.
RESULTS
Mean± SD concentration of salivary testosterone was 40.39±
13.39 pg/ml in males and 39.70± 16.64 pg/ml in females and
did not differ significantly (p= 0.73). This is likely a conse-
quence of differing correlations between salivary testosterone
and serum testosterone in males and females. According to Sali-
metrics, the relationship between serum and saliva for males as
determined by linear regression is y (total serum testosterone in
nanogram per milliliter)= 0.2421+ 0.0496× x (salivary testos-
terone in picogram per milliliter). The linear regression equation
for females is y (total serum testosterone in nanogram per mil-
liliter)= 0.1415+ 0.0055× x (salivary testosterone in picogram
per milliliter). Assuming that the relationship between total serum
testosterone and salivary testosterone in infants is similar to that
seen in adults; we would estimate a mean serum level of 2.25 ng/ml
for male infants and 0.36 ng/ml for female infants, which is com-
parable to published reports on serum testosterone levels in this
age range (39, 40).
Mean± SD for transferrin was 0.844± 0.93 mg/dl in males
and 0.91± 0.98 mg/dl in females. A moderate correlation between
transferrin and testosterone was observed in both males and
females (r = 0.28, p= 0.002 and r = 0.43, p< 0.001, respectively).
Transferrin levels were higher than expected, which raises the pos-
sibility of blood contamination. We addressed this issue in two
ways. (1) In all our primary analyses, we included transferrin as
a covariate. Specifically, we adjusted for log(10)transferrin as the
untransformed variable showed high levels of skewness and kur-
tosis. (2) For the environmental association analysis, univariate
genetic analyses, and RF analysis, we also performed sensitivity
analyses in infants with transferrin levels <0.50 mg/dl [cut-off
based on the recommendation of Granger et al. (41)]. For ICC and
heritability estimation, we did not perform sensitivity analyses due
to insufficient sample size.
ENVIRONMENTAL ASSOCIATION ANALYSIS
The final model for males using adaptive Lasso included 5 min
APGAR score in addition to the fixed variables, log(10)transferrin,
and age since DOB. Bootstrapping supported the importance of
5 min APGAR score in that it was selected in 837 out of 1000
tests (see Table 3). A linear mixed effect model including these
variables explained approximately 32% of the variance in salivary
testosterone. Examination of a linear mixed effect model includ-
ing all predictors confirmed that 5 min APGAR score was the only
major demographic or medical history variable examined which
significantly predicted salivary testosterone in males after Bon-
ferroni correction (0.05/29 predictors= 0.0017) and explained
approximately 15% of the variance. In males with transferrin lev-
els <0.50 mg/dl, a linear mixed model including age since DOB
and 5 min APGAR score explained 22% of the variance in salivary
Table 3 | Bootstrapping results.
Male Female
Transferrina (fixed) 1000 1000
Age since DOB (fixed) 1000 1000
NICU Stay >24 h 43 26
Birth weight 152 84
Gestational age birth 54 28
Maternal ethnicity (White vs. Black) 122 114
Maternal ethnicity (White vs. Asian) 132 3
Maternal ethnicity (White vs. American Indian) 83
Paternal ethnicity (White vs. Black) 122 9
Paternal ethnicity (White vs. Asian) 8 22
Maternal education 49 23
Paternal education 92 17
Maternal age 110 12
Paternal age 118 19
Maternal psych history 111 6
Paternal psych history 184 11
Income (low vs. middle) 48 141
Income (low vs. high) 410 35
Income (low vs. missing) 39 379
5-Min APGAR 837 20
Gestation number 103 43
C-section 227 32
Smoking 126 5
aLog(10)transferrin.
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Table 4 | Association of salivary testosterone with demographic and
medical history variables in males.
Model R2 Predictors Beta Sig r2
Mixed effect
model (selected
variables)
0.32 Intercept 110.07
Transferrina 17.36 <0.001 0.24
Age since DOB −5.84 0.08 0.02
5 Min APGAR −5.26 <0.001 0.08
Full mixed effect
model
0.39 Intercept 183.68
Transferrina 17.89 <0.001 0.23
Age since DOB −7.99 0.02 0.04
NICU >24 h −2.87 0.44 <0.01
Birth weight 0.00 0.49 0.01
Gestational age birth −0.10 0.40 0.02
Mat ethnicity 0.05
White −14.60 0.20
Black −12.56 0.12
American Indian −25.34 0.05
Pat ethnicity 0.51
White 2.99 <0.01
Black 0.13 <0.01
Mat education −0.05 0.94 <0.01
Pat education −0.64 0.35 0.02
Mat age −0.24 0.55 <0.01
Pat age 0.31 0.50 0.02
Mat psych history 2.71 0.51 <0.01
Pat psych history −6.07 0.17 0.02
Income 0.08
High 3.85 0.02
Middle −0.71 <0.01
Missing 7.78 <0.01
5-Min APGAR −7.57 <0.001 0.15
Gestation number −3.18 0.38 0.01
C-section −3.34 0.18 0.01
Mat smoking 2.53 0.60 <0.01
Reduced mixed
effect model in
infants with
transferrin
<0.5 ng/dl
0.22 Intercept 105.03
Age since DOB −2.93 0.50 <0.01
5-Min APGAR −7.07 <0.001 0.22
aLog(10)transferrin.
testosterone (see Table 4). The final model for females using adap-
tive Lasso only included the fixed variables, log(10)transferrin, and
age since DOB. A mixed effect model including these variables
explained approximately 18% of the variance in salivary testos-
terone. Examination of a mixed effect model including all predic-
tors confirmed that none of the demographic or medical history
variables examined significantly predicted salivary testosterone in
females after Bonferroni correction (0.05/29 predictors= 0.0017).
In females with transferrin levels <0.50 mg/dl, a mixed model
including age since DOB explained 1% of the variance in sali-
vary testosterone (see Table 5). Given the converging evidence for
the importance of 5 min APGAR score on salivary testosterone in
males, it was included as a covariate in subsequent analyses.
Table 5 | Association of salivary testosterone with demographic and
medical history variables in females.
Model R2 Predictors Beta Sig r2
Mixed effect
model (selected
variables)
0.18 Intercept 57.37
Transferrina 14.24 <0.001 0.15
Age since DOB −4.86 0.28 0.01
Full mixed effect
model
0.41 Intercept 70.37
Transferrina 15.71 <0.001 0.16
Age since DOB −5.73 0.20 0.01
NICU stay >24 h −6.41 0.27 0.02
Birth weight −0.01 0.08 0.07
Gestational age birth 0.06 0.72 <0.01
Mat Ethnicity 0.24
White −5.03 0.01
Black 3.01 <0.01
Pat ethnicity 0.16
White 14.02 0.11
Black 8.37 0.03
Mat education 0.43 0.58 <0.01
Pat education 0.24 0.73 <0.01
Mat age 0.16 0.74 <0.01
Pat age −0.21 0.62 <0.01
Mat psych history 0.18 0.96 <0.01
Pat psych history −2.67 0.64 <0.01
Income 0.004
High −2.59 <0.01
Middle 2.87 <0.01
Missing −28.57 0.05
5-Min APGAR −0.97 0.66 <0.01
Gestation number −6.03 0.23 0.03
C-section −0.26 0.94 <0.01
Mat smoking 1.53 0.79 <0.01
Reduced mixed
effect model in
infants with
transferrin
<0.5 ng/dl
0.01 Intercept 17.89
Age since DOB 3.48 0.22 0.01
aLog(10)transferrin.
INTRACLASS CORRELATION COEFFICIENT AND HERITABILITY
ESTIMATION
The intraclass correlations for MZ and DZ twins are shown in
Figure 3 and suggest a high environmental component and a low
genetic component for both sexes. The ACE model confirmed that
the majority of variation in salivary testosterone was explained by
shared environmental factors in both sexes (see Table 6).
UNIVARIATE GENETIC ASSOCIATION ANALYSIS
In males, no SNPs were significantly associated with salivary testos-
terone levels after adjusting for FDR in the full sample. The most
significant association was for rs10923844, a variant of unknown
function located downstream of HSD3B1 and HSD3B2 (adjusted
p-value= 0.07, unadjusted p= 0.0002). This same SNP had an
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FIGURE 3 | Intraclass correlations within twin pairs are shown. MZM
(monozygotic male), DZM (dizygotic male), MZF (monozygotic female), and
DZF (dizygotic female).
Table 6 | Univariate genetic model.
Variance explained (%) p-value
Males
A 0 0.81
C 62.7 <0.001
Females
A 19.1 0.36
C 41.8 0.19
Percentages of phenotypic variation explained by additive genetic (A) and shared
environmental (C) factors.
unadjusted p-value of 0.02 in the subsample of males with trans-
ferrin<0.50 mg/dl. Effect sizes for this variant were highly similar
in the total male sample [adjusting for log(10)transferrin] and the
subsample of males with transferrin<0.50 mg/dl (Beta= 6.26 and
6.02, respectively). Indeed, effect sizes for the full male sample are
highly similar to the corresponding effect sizes in the subset of
males with transferrin <0.50 mg/dl (see Figure 4). None of the
previous GWAS hits for serum testosterone levels in adult males
were significantly associated with salivary testosterone in infant
males before or after adjusting for FDR in either the full sample
or the subset of males with transferrin <0.50 mg/dl. In females,
no SNPs were significantly associated with salivary testosterone
levels after adjusting for FDR. The most significant associations
were for two SNPs located upstream of ESR1 (rs3407085 and
rs2295190) within the intron region of SYNE1 (spectrin repeat
containing, nuclear envelope (1); adjusted and unadjusted p-values
were 0.09 and 0.0004 for both variants (these variants are in com-
plete linkage disequilibrium within our sample). Both variants
had an unadjusted p-value of 0.04 in the subsample of females
FIGURE 4 | Correlation between effect sizes in full samples [correcting
for log(10)transferrin] and subsamples with transferrin levels
<0.50 mg/dl.
with transferrin <0.50 mg/dl. Effect sizes were highly similar for
the total female sample [adjusting for log(10)transferrin] and the
subsample of females with transferrin<0.50 mg/dl (Beta=−13.7
and−11.2, respectively), though we note that effect sizes for the full
female sample do not correspond as well to the effect sizes in the
reduced sample as compared to males (See Figure 4). Full results
are available as supplemental data. Power calculations indicate that
theoretically, our analysis is well-powered to identify variants with
Beta values >6 in the MAF range examined (see Figure 5).
Frontiers in Endocrinology | Pediatric Endocrinology October 2014 | Volume 5 | Article 187 | 8
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Xia et al. Contributors to salivary testosterone
FIGURE 5 | Plots demonstrating the relationship between statistical power, minor-allele frequencies, and effect size are shown.
RANDOM FORESTS
Tables 7 and 8 display the top SNPs in males and females, respec-
tively, defined as the intersection of the top 30 variables obtained
from each of 50 RF runs. Also included in the table are the beta.hat,
likelihood ratio, and unadjusted and FDR adjusted p-values from
the univariate association tests. In males, regulators of repro-
ductive function appear to play an important role. Specifically,
multiple variants in or near LHCGR were consistently selected
as high importance. Multiple SNPs in genes related to choles-
terol production, transport, and removal were also selected. These
genes included DHCR7, TSPO, CYP7A1, and POR. The top hit
from the univariate analyses (rs10923844) was selected, as were
two variants near the Xp22 loci identified in GWAS studies of
serum testosterone in adult males. Analyses in the subset of males
with transferrin <0.50 mg/dl supported the importance of regu-
lators of reproductive function and cholesterol-related genes. Five
SNPs were selected as high importance in both the full and reduced
male sample; these were rs4952922, rs10495960, and rs2301267 (all
in/near LHCGR), rs47340 (TSPO), and rs74091680 (HSD17B6).
In females, genes related to estrogen signaling appear to play an
important role. Specifically, variants in ESR1, CYP19A1, CYP1B1,
and HSD17B8 were consistently selected as high importance in
the full sample. Analyses in the subset of females with transfer-
rin <0.50 mg/dl supported the importance of estrogen signaling,
although the specific SNPs differed. Two SNPs were selected as
high importance in both the full and reduced female sample; these
were rs4149448 (SULT2A1) and rs4659175 (HSD3B2).
DISCUSSION
This study provides the first detailed analysis of environmen-
tal and genetic contributors to variation in salivary testosterone
during the minipuberty, a developmental period that plays a crit-
ical role in genital development and sexual differentiation of the
brain. As such, it should be considered exploratory and requires
replication. Twin modeling indicated that individual variability
in testosterone levels in the minipuberty is primarily explained
by environmental factors. In terms of specific environmental
contributors, we observed a consistent and robust association
between 5 min APGAR scores and salivary testosterone levels
in males. In terms of specific genetic contributors, univariate
tests did not reveal any variants significantly associated with sali-
vary testosterone after adjusting for FDR. However, we note that
this approach is underpowered for identifying SNPs with small
effect sizes. The top hit in males was rs10923844, an SNP of
unknown function located downstream of HSD3B1 and HSD3B2.
The top hits in females were two SNPs located upstream of ESR1
(rs3407085 and rs2295190). RF analysis, which reflects joint and
conditional effects of multiple variables, including those with small
individual effect sizes, suggests that genes involved in regulation
of reproductive function and cholesterol production, transport,
and removal are involved in individual variation in salivary testos-
terone in males, while genes involved in estrogen signaling are
important in females.
MAJOR DEMOGRAPHIC AND MEDICAL HISTORY VARIABLES AND
SALIVARY TESTOSTERONE
Higher APGAR scores taken 5 min post-birth were associated with
lower salivary testosterone levels in males during the minipu-
berty. APGAR scores were originally designed to quickly evaluate
a newborn’s physical condition and to identify any immediate
need for extra medical or emergency care. The APGAR score
includes five components: heart rate, respiratory effort, muscle
tone, reflex irritability, and color, each of which is given a score
of 0, 1, or 2 with 2 being the best score (42). A number of factors
may influence an APGAR score, including hypoxia, exposure to
drugs, trauma, congenital anomalies, infections, and hypovolemia
(43). While primarily conceived as a measure of short peripar-
tum stress, some researchers have suggested that it also indexes
a suboptimal fetal environment (44). Studies in rodent models
provide compelling evidence that the stress response induced by
physical or emotional challenges in fetal life affects later reproduc-
tive function (45–47). Regarding the HPG axis, maternal stress
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Table 7 | Random forest results males.
SNP beta.hat lr mChr mPos pval pval.bh Index gene Function class
FULL SAMPLE
rs10923844 6.26 13.42 chr1 120000000 0.0002 0.07 HSD3B1 Downstream
rs2301267 5.66 12.38 chr2 48984391 0.0004 0.07 LHCGR Upstream (LHCGR) intronic (STON1-GTF2A1L)
rs11897846 2.94 3.29 chr2 48956512 0.07 0.66 LHCGR Intronic
rs10495960 3.97 3.26 chr2 48960032 0.07 0.66 LHCGR Intronic (LHCGR) missense (GTF2A1L)
rs4952922 4 3.29 chr2 48961396 0.07 0.66 LHCGR Intronic
rs988328 −6.6 8.42 chr6 152000000 0.004 0.35 ESR1 Intronic
rs4728533 1.82 0.75 chr7 75586536 0.38 0.90 POR Intronic
rs10504255 3.63 3.64 chr8 59398461 0.06 0.66 CYP7A1 Downstream
rs1004467 4.04 2.85 chr10 105000000 0.09 0.66 CYP17A1 Intronic
rs12419334 4.62 7.34 chr11 71139472 0.007 0.38 DHCR7 Downstream
rs12797951 4.17 6.26 chr11 71143266 0.01 0.57 DHCR7 Downstream
rs74091680 7.75 7.47 chr12 57154822 0.006 0.38 HSD17B6 Intronic
rs47340 5.66 12.8 chr22 43562829 0.0003 0.07 TSPO Downstream (TSPO) 3 prime UTR (TTLL12)
rs139036121 −0.21 0.03 chrX 8912628 0.87 0.96 Xp22 near GWAS hit Intergenic b/t FAM9A and FAM9B
rs5934508 −0.1 0.01 chrX 8918776 0.92 0.97 Xp22 near GWAS hit Intergenic b/t FAM9A and FAM9B
SUBSET WITHTRANSFERRIN <0.50 ng/dl
rs56058466 9.15 6.42 chr2 38328870 0.01 0.21 CYP1B1 Upstream
rs4952922 11.36 17.97 chr2 48961396 0.00002 0.006 LHCGR Intronic
rs10495960 11.30 17.81 chr2 48960032 0.00002 0.0006 LHCGR Intronic (LHCGR) missense (GTF2A1L)
rs2301267 7.37 13.36 chr2 48984391 0.0003 0.03 LHCGR Upstream
rs4245818 8.94 10.78 chr2 48985607 0.001 0.06 LHCGR Upstream (LHCGR) Intronic (STON1-GTF2A1L)
rs11682325 9.86 6.56 chr2 48899807 0.01 0.21 LHCGR Downstream (LHCGR
Intronic (STON1-GTF2A1L)
rs2031367 8.74 7.83 chr6 87807180 0.01 0.17 CGA Upstream
rs6937568 12.46 5.22 chr6 152153964 0.02 0.28 ESR1 Intronic
rs62442039 13.38 12.90 chr6 152158090 0.0003 0.03 ESR1 Intronic
rs10954724 −4.19 3.16 chr7 75597545 0.08 0.46 POR Intronic
rs17148944 10.69 5.96 chr7 75601867 0.01 0.23 POR Intronic
rs800667 2.91 0.41 chr7 99447241 0.52 0.81 CYP3A43 Synonymous
rs881671 −21.87 12.79 chr8 59417107 0.0003 0.03 CYP7A1 Upstream
rs8190495 5.80 7.09 chr9 99061884 0.01 0.18 HSD17B3 Intronic
rs8190478 6.23 9.07 chr9 99064883 0.003 0.12 HSD17B3 Upstream
rs74091680 7.59 2.03 chr12 57154822 0.15 0.55 HSD17B6 Intronic
rs2277339 2.67 0.47 chr12 57146069 0.49 0.82 HSD17B6 Upstream (HSD17B6 ) missense (PRIM1)
rs47340 6.61 6.83 chr22 43562829 0.01 0.20 TSPO Downstream (TSPO) 3 prime UTR (TTLL12)
during pregnancy disrupts the prenatal surge of testosterone that
normally occurs in the developing male rat (48, 49) and is asso-
ciated with reduced testosterone levels in adult rats (50). No
studies have examined stress response during labor and deliv-
ery and its impact on reproductive function. Physical stressors
associated with lower APGAR scores may explain the association
between 5 min APGAR scores and salivary testosterone in males
observed in our study, although the direction of effect is oppo-
site to that reported for prenatal stress in rodents. We note that
while 5-min Apgar score is a valid predictor of neonatal mortality,
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Table 8 | Random forest results females.
SNP beta.hat lr mChr mPos pval pval.bh Index gene Function class
FULL SAMPLE
rs4659175 −3.44 2.08 chr1 119956473 0.15 0.80 HSD3B2 Upstream
rs4952222 1.58 0.13 chr2 31799863 0.72 0.97 SRD5A2 Intronic
rs56058466 6.90 4.73 chr2 38328870 0.03 0.52 CYP1B Upstream
rs1547387 −8.21 5.75 chr6 33169895 0.02 0.39 HSD17B8 Upstream (HSD17B8 ) synonymous (SLC39A7)
rs11155820 1.43 0.29 chr6 152204210 0.59 0.96 ESR1 Intronic
rs62443560 −13.68 6.59 chr6 152190476 0.01 0.35 ESR1 Intronic
rs2982683 2.95 1.37 chr6 152298435 0.24 0.91 ESR1 Intronic
rs17081685 1.46 0.14 chr6 152116655 0.71 0.97 ESR1 Intronic
rs3798758 −5.50 1.37 chr6 152421854 0.24 0.91 ESR1 3 prime UTR
rs2899472 −0.46 0.04 chr15 51516055 0.85 0.99 CYP19A1 Intronic
rs9939740 −2.96 1.54 chr16 82121981 0.21 0.88 HSD17B2 Intronic
rs6259 −4.61 1.56 chr17 7536527 0.21 0.88 SHBG Missense
rs4149448 5.52 2.68 chr19 48386357 0.10 0.69 SULT2A1 Intronic
rs138929 −4.78 3.44 chr22 43562439 0.06 0.58 TSPO Downstream
rs57484470 5.01 0.87 chr22 43545077 0.35 0.92 TSPO Upstream
rs6971 −4.70 2.89 chr22 43558926 0.09 0.68 TSPO Missense
rs7058445 −2.03 0.67 chrX 7172508 0.41 0.94 STS Intronic
SUBSET WITHTRANSFERRIN<0.50 ng/dl
rs4659175 −3.76 2.32 chr1 119956473 0.13 1 HSD3B2 Upstream
rs10923844 −4.58 2.84 chr1 120059500 0.09 0.90 HSD3B1 Downstream
rs232535 −0.60 0.04 chr2 38332303 0.85 1 CYP1B1 Upstream
rs162557 −2.85 1.17 chr2 38305451 0.28 1 CYP1B1 Upstream
rs28585480 −7.35 7.02 chr4 74290918 0.01 0.86 ALB Downstream
rs2747653 6.47 −1.19 chr6 152446057 1.00 1 ESR1 Downstream (ESR1) intronic (SYNE1)
rs10224569 10.19 0.33 chr7 99248304 0.57 1 CYP3A5 Intronic
rs12537277 −0.61 0.04 chr7 75588704 0.84 1 POR Intronic
rs10135310 9.95 −0.28 chr14 64574140 1.00 1 ESR2 Downstream (ESR2) intronic (SYNE2)
rs2781377 10.02 −1.42 chr14 64560092 1.00 1 ESR2 Downstream (ESR2) stop gained (SYNE2)
rs41334947 10.02 −1.42 chr14 64560091 1.00 1 ESR2 Downstream (ESR2) missense(SYNE2)
rs57018718 10.02 −1.42 chr14 64594019 1.00 1 ESR2 Downstream (ESR2) intronic (SYNE2)
rs2414095 −6.29 0.57 chr15 51524292 0.45 1 CYP19A1 Intronic
rs12591359 2.23 0.68 chr15 51539368 0.41 1 CYP19A1 Intronic
rs4149448 4.08 2.03 chr19 48386357 0.15 1 SULT2A1 Intronic
rs2910400 3.56 1.41 chr19 48394042 0.24 1 SULT2A1 Upstream
its predictive value for other outcomes continues to be debated
(43). Never-the-less, this scoring system remains the only widely
used and accepted tool for assessing the vitality of newborn infants
across the world. We also note that the majority of children in our
sample had 5-min Apgar scores between 7 and 10, which is con-
sidered normal, with only a few falling in the intermediate range
(scores between 4 and 6). Additional research is necessary to repli-
cate these findings, determine if they extend to individuals with
lower APGAR scores, and understand underlying mechanisms.
None of the major demographic or maternal history variables
examined in this study impacted salivary testosterone levels in
females.
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HERITABILITY OF SALIVARY TESTOSTERONE
Our results suggest that individual variability in salivary testos-
terone levels in the minipuberty is predominantly explained by
environmental factors. Our findings are similar to those reported
by Caramaschi et al. (28) in older infants, but contrast with studies
in adolescents and adults, which show high heritability, especially
in males (17–23). Caramaschi et al. (28) suggested that the puber-
tal rise in male testosterone levels has a strong genetic component
and that testosterone levels are less influenced by genetic factors
when male and female levels are similar and very low as is the
case in later infancy. Salivary testosterone levels in our study were
significantly higher than those reported by Caramaschi et al. (28):
40.39 vs. 9.60 pg/ml in boys and 39.70 vs. 8.93 pg/ml in girls, but
are lower than those reported for adults: 163.81 and 60.86 pg/ml
for males and females, respectively (51). Salivary testosterone did
not differ significantly between males and females in our sam-
ple, but estimated serum levels exhibited a sex difference, which is
comparable to published reports on serum testosterone levels in
this age range (39, 40). Therefore, our results suggest that environ-
mental factors play a stronger role than genetic factors during the
minipuberty despite moderately high testosterone levels and sex
differences in serum testosterone. Identifying the environmental
factors involved is an important area for future research.
GENETIC FACTORS INFLUENCING SALIVARY TESTOSTERONE
Although our heritability analysis indicated that environmental
risk factors play a larger role in determining individual variation
in salivary testosterone during the minipuberty than genetic fac-
tors, deciphering the genetic component is still important in terms
of understanding underlying biochemical pathways. We were also
mindful of the fact that heritability by itself does not provide infor-
mation about the genetic architecture of traits. In principle, a trait
with a low heritability can have a single locus that causes variation
and a trait with a high heritability can have hundreds of contribut-
ing loci (52). The presence of gene–environment correlations and
interactions also introduces systematic biases in heritability esti-
mates made under the independence assumption in twin studies,
which can result in an underestimation of the genetic compo-
nent (53) For all these reasons, we performed univariate genetic
association analyses and RF analyses of SNPs within ±5 kb of
genes involved in testosterone synthesis, transport, signaling, and
metabolism for their relationship with salivary testosterone.
No SNPs were significantly associated with salivary testosterone
levels after adjusting for FDR in the full male sample or the full
female sample. Simulations indicated that theoretically we were
well-powered to detect significant SNPs with Beta values >6 within
the range of minor-allele frequencies we examined. Thus, our
study suggests that common variants with large effect sizes do
not play a role in individual differences in salivary testosterone in
infants, at least within the genes examined. The top hit in males
was rs10923844, a variant of unknown function located down-
stream of HSD3B1 and HSD3B2, two genes that play a critical role
in steroidogenesis. This variant was also identified as an impor-
tant variable in the RF analysis. Both isoforms of 3-beta-HSD
convert pregnenolone to progesterone, 17α-hydroxypregnenolone
to 17α-hydroxyprogesterone, dehydroepiandrosterone (DHEA) to
androstenedione, and androstenediol to testosterone. Type 1 is
primarily expressed in the placenta and non-steroidogenic tis-
sues, while type 2 is primarily expressed in the adrenals and
gonads (54). The top hits in females were two SNPs located
upstream of ESR1 (rs3407085 and rs2295190), the gene coding
for estrogen receptor alpha, one of two main types of estrogen
receptor.
It is increasingly recognized that individual variation in com-
plex phenotypes results, in part, from the joint and condi-
tional effects of many common SNPs whose individual effect
sizes are relatively small, making them difficult to identify via
standard univariate analyses (55, 56). RF analysis represents a
promising approach to this problem and is well-suited to high-
dimension, low-sample-size data typical of genetic association
studies. RF analysis suggested that regulators of reproductive
function and genes related to cholesterol production, transport,
and removal play an important role in salivary testosterone lev-
els in males. Five SNPs were selected as high importance in
both the full and reduced male sample and thus are particu-
larly promising candidates for follow-up. rs4952922, rs10495960,
and rs2301267 are all located in/near LHCGR, which codes for
the LH/choriogonadotropin receptor. rs47340 is located down-
stream of TSPO, which codes for a protein that interacts with
StAR (steroidogenic acute regulatory protein) to transport cho-
lesterol into mitochondria to permit steroid synthesis [data on
gene functions from www.genecards.org (57), SNP locations from
dbSNP (58) and UCSC genome browser (59)]. rs74091680 is an
intronic variant in HSD17B6, which codes for an enzyme involved
in androgen catabolism. Specifically, the oxidoreductase activ-
ity can convert 3 alpha-adiol to dihydrotestosterone, while the
epimerase activity can convert androsterone to epi-androsterone.
Interestingly, two variants near the Xp22 loci identified in GWAS
studies of serum testosterone in adult males (24, 25) were selected
in the primary RF analysis. This suggests that some genetic factors
influencing testosterone levels are active throughout the lifes-
pan, although this finding was not recapitulated in the subsample
analysis.
In females, RF analysis suggested that genes related to estro-
gen signaling play an important role. Specifically, variants in/near
ESR1,CYP19A1,CYP1B1, andHSD17B8 were consistently selected
as high importance in the full sample. ESR1 codes for estro-
gen receptor alpha, one of two main types of estrogen receptor.
CYP19A1 codes for aromatase, the enzyme responsible for the con-
version of androgens into estrogens. CYP1B1 codes for an enzyme
that metabolizes multiple compounds, including 17β-estradiol.
HSD17B8 inactivates estrogens and androgens, with high activity
toward estrogen and low activity toward testosterone. It can also
synthesize estradiol from estrone. Analyses in the subset of females
with transferrin <0.50 mg/dl supported the importance of estro-
gen signaling, although the specific SNPs implicated differed. Two
SNPs were selected as high importance in both the full and reduced
female sample; these were rs4149448 (SULT2A1) and rs4659175
(HSD3B2). SULT2A1 codes for a protein, which catalyzes the sul-
fation of steroids and bile acids in the liver and adrenal glands,
and may have a role in the inherited adrenal androgen excess in
women with polycystic ovary syndrome (60). HSD3B2 codes for
an enzyme with a critical role in the biosynthesis of all classes of
steroid hormones.
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LIMITATIONS
The primary limitation of the current study is the use of salivary
testosterone levels rather than plasma testosterone levels. While
plasma and serum are the traditional matrices for the determina-
tion of endocrine parameters including testosterone, saliva offers a
non-invasive and stress-free alternative, which enjoys widespread
acceptance and has been used for over 40 years (61). In men,
salivary testosterone is strongly correlated with the free fraction
of testosterone in serum (r = 0.64–0.97) (51, 62–64). In women,
reported correlations are more moderate (r = 0.37–0.85) (51, 63,
65). There is no a priori reason to presume that correlations
between serum and saliva are different in the neonate, although
this has not been directly tested. Collection of saliva maximized
parental acceptability and minimized child distress. It is unlikely
that we would have achieved a reasonable sample size if we opted
to use blood. Substitution of saliva assay results for serum values is
known to underestimate testosterone–behavior associations, pri-
marily in females, and this problem may also be applicable to the
environmental and genetic associations, which were the focus of
this study. Null results, especially in females, should be treated with
caution.
We also observed higher levels of transferrin in saliva than
expected and moderate correlations between transferrin and
testosterone in both sexes (stronger in females), which raises the
possibility of blood contamination. For comparison, Granger et al.
(41), in a study of children between 6 and 13 years of age, reported
a mean± SD for transferrin of 0.37± 0.46 mg/dl and a correlation
with testosterone of 0.058. Unfortunately, although the transfer-
rin assay (66) has been available for over a decade, it has not been
routinely used in studies of infants making it difficult to deter-
mine if the levels that we observed are typical for this age or not.
Reassuringly, the mean± SD for salivary testosterone in our study
was highly similar to that reported by other studies in our age
range (11) and estimated serum levels are comparable to pub-
lished reports on serum testosterone in this age range (39, 40). We
also addressed this issue statistically. In all our primary analyses,
we included transferrin as a covariate. In addition, for the envi-
ronmental association analysis, univariate genetic analyses, and RF
analysis, we performed sensitivity analyses in infants with trans-
ferrin levels <0.50 mg/dl (cut-off based on the recommendation
of Granger et al. (41). In general, relationships identified in the full
sample were also present in the subsample with transferrin levels
<0.50 mg/dl. Finally, we note that collecting samples on multiple
days would have allowed a more precise evaluation of individual
differences in testosterone levels, but was deemed impractical. The
sample size for twin modeling was also somewhat underpowered.
CONCLUSION
Despite these limitations, the current study provides novel infor-
mation about the environmental and genetic contributors to
testosterone levels in the early post-natal period. In contrast to
the strong genetic contributions observed during puberty, tran-
sient activation of the HPG axis in the early post-natal period
appears to be heavily influenced by environmental factors. We
identified 5 min APGAR score as a significant predictor of salivary
testosterone levels in males. Further research is needed to elucidate
the biological mechanisms underlying this relationship. Our study
also suggests that genetic variants in regulators of reproductive
function and cholesterol play an important role in salivary testos-
terone levels in males, while genes related to estrogen signaling
play an important role in females. All results require replication,
preferably with serially collected serum samples. Ideally, such a
study would also include measures of prenatal testosterone in
amniotic fluid or through cordocentesis, providing insight into
the genetic architecture of the prenatal testosterone surge as well
as the neonatal surge.
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